NCT04528407Completed
BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects
Follow-up Study for Patients Having Received FluBHPVE6E7 in Clinical Studies
Source: ClinicalTrials.gov · Last updated 13 Feb 2025
Brief summary (registry, in English)
This is a follow-up study for patients treated with FluBHPVE6E7 in previous interventional studies.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 25 (actual)
- First submitted
- 20 Aug 2020
- Start date
- 9 Apr 2021
- Primary completion date
- 31 Jan 2025
- Lead sponsor
- BlueSky Immunotherapies GmbH
- NCT number
- NCT04528407
What you commit to
- Study type: Observational
- Participants enrolled: 25
- From 9 Apr 2021 to the primary completion date, 31 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnancy, breastfeeding
Who the study is looking for
- Patient who enrolled in previous phase 1 or 2 clinical studies of FluBHPVE6E7
- Negative pregnancy test at baseline
- Written informed consent
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Vienna Coordinator of this site? Confirm its status | Vienna | Austria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.